| Sources | Names Used |
|---|---|
| CTRPv2 | triazolothiadiazine |
| PharmacoGx | triazolothiadiazine |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GGCX | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | TRIM51 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | FANCG | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | TMSB15A | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | GPR63 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | SASS6 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | BAZ1B | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | GATAD2B | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | EMILIN3 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | TMPO | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
